Image
illustration
Venture Capital Acquisitions & Partnerships

Alcon to acquire IVANTIS Inc.

Wednesday 10 November, 2021
Body

Ivantis® is the developer and manufacturer of the novel Hydrus® Microstent, a minimally-invasive glaucoma surgery (MIGS) device designed to lower intraocular pressure for open-angle glaucoma patients in connection with cataract surgery.

Content